Welcome to our in vivo tumor research platform, meticulously designed for pre-clinical studies in oncology and tumor immunotherapy. Our platform integrates a range of cutting-edge techniques and experimental methods aimed at offering researchers the most comprehensive and realistic drug evaluation environment.
Platform Features:
• CDX: Conventional patient-derived xenograft models used for evaluating drug efficacy and anti-tumor activity.

• Syngeneic: The homologous model uses immunocompetent mice to establish a homologous transplantation model of mouse derived tumors. Due to their completely natural immune system, these mice are an ideal choice for testing various immune therapies. This model can provide immune response data that is closer to clinical conditions.
• iHuPDX: Humanized patient-derived xenograft models, closer to the actual human environment, providing higher accuracy for drug evaluations.
• Syngenic Surgical Models:
    • Brain Syngenic Model: Simulates the growth and treatment response of brain tumors, providing key data for central nervous system drug evaluations.
    • Other Syngenic Models: Simulates the growth and treatment response of tumors in other organs, covering a wide range of tumor types.
• Hematologic Tumor Systemic Inoculation: Specifically designed to evaluate the growth and treatment response of hematologic tumor cells after intravenous inoculation, offering crucial insights for hematologic tumor treatment strategies.
Our in vivo tumor research platform combines a multitude of advanced techniques, offering comprehensive support for your oncology and tumor immunotherapy research. Should you have any questions or require further insights, please don't hesitate to contact us.